205 related articles for article (PubMed ID: 26951097)
1. The efficacy of iodine-125 permanent brachytherapy versus intensity-modulated radiation for inoperable salivary gland malignancies: study protocol of a randomised controlled trial.
Liu SM; Wang HB; Sun Y; Shi Y; Zhang J; Huang MW; Zheng L; Lv XM; Zheng BM; Reilly KH; Yan XY; Ji P; Wu YF; Zhang JG
BMC Cancer; 2016 Mar; 16():193. PubMed ID: 26951097
[TBL] [Abstract][Full Text] [Related]
2. COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.
Jensen AD; Nikoghosyan AV; Lossner K; Haberer T; Jäkel O; Münter MW; Debus J
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):37-46. PubMed ID: 26279022
[TBL] [Abstract][Full Text] [Related]
3. Postoperative iodine-125 interstitial brachytherapy for the early stages of minor salivary gland carcinomas of the lip and buccal mucosa with positive or close margins.
Wu WJ; Shao X; Huang MW; Lv XM; Zhang XN; Zhang JG
Head Neck; 2017 Mar; 39(3):572-577. PubMed ID: 28075511
[TBL] [Abstract][Full Text] [Related]
4. Management and outcome of patients with malignant salivary gland tumors.
Bell RB; Dierks EJ; Homer L; Potter BE
J Oral Maxillofac Surg; 2005 Jul; 63(7):917-28. PubMed ID: 16003616
[TBL] [Abstract][Full Text] [Related]
5. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
[TBL] [Abstract][Full Text] [Related]
6. IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial.
Jensen AD; Nikoghosyan AV; Lossner K; Herfarth KK; Debus J; Münter MW
BMC Cancer; 2012 May; 12():163. PubMed ID: 22551422
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
Forsythe K; Blacksburg S; Stone N; Stock RG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
[TBL] [Abstract][Full Text] [Related]
8. The role of
Huang MW; Wu WJ; Lv XM; Yu GY; Zhang JG
Brachytherapy; 2018; 17(1):244-249. PubMed ID: 29102739
[TBL] [Abstract][Full Text] [Related]
9. [Operation plus brachytherapy of iodine 125 seeds implantation for salivary gland malignant tumors].
Zhang M; Liu Y; Xi Q; Bu RF; Zhang HZ; Zhang L; Liang LM; Yang G; Chen F
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(42):2992-4. PubMed ID: 23328292
[TBL] [Abstract][Full Text] [Related]
10. [Radioactivity seeds interstitial brachytherapy treating malignant salivary gland tumors].
Zhang J; Zheng L; Huang MW; Liu SM; Jia LF; Shi Y; Yu GY; Zhang JG
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):272-5. PubMed ID: 21503125
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC.
Jensen AD; Nikoghosyan A; Windemuth-Kieselbach C; Debus J; Münter MW
BMC Cancer; 2010 Oct; 10():546. PubMed ID: 20937120
[TBL] [Abstract][Full Text] [Related]
12. Ten year experience with surgery and radiation in the management of malignant major salivary gland tumors.
Iqbal H; Bhatti AB; Hussain R; Jamshed A
Asian Pac J Cancer Prev; 2014; 15(5):2195-9. PubMed ID: 24716956
[TBL] [Abstract][Full Text] [Related]
13. Iodine-125 brachytherapy improved overall survival of patients with inoperable stage III/IV non-small cell lung cancer versus the conventional radiotherapy.
Li W; Guan J; Yang L; Zheng X; Yu Y; Jiang J
Med Oncol; 2015 Jan; 32(1):395. PubMed ID: 25428394
[TBL] [Abstract][Full Text] [Related]
14. 3D-printed individualized tooth-borne tissue retraction devices compared to conventional dental splints for head and neck cancer radiotherapy: a randomized controlled trial.
Held T; Herpel C; Schwindling FS; Christ L; Lang K; Regnery S; Eichkorn T; Hommertgen A; Jaekel C; Krisam J; Moratin J; Mrosek J; Metzger K; Zaoui K; Moutsis T; Harrabi S; Herfarth K; Freudlsperger C; Rammelsberg P; Debus J; Adeberg S
Radiat Oncol; 2021 Apr; 16(1):75. PubMed ID: 33865401
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.
Al-Qahtani KH; Tunio MA; Bayoumi Y; Gurusamy VM; Bahamdain FA; Fatani H
J Otolaryngol Head Neck Surg; 2016 May; 45(1):32. PubMed ID: 27184361
[TBL] [Abstract][Full Text] [Related]
16. [
Yu HB; Wu WJ; Lv XM; Shi Y; Zheng L; Zhang JG
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):919-923. PubMed ID: 33047730
[TBL] [Abstract][Full Text] [Related]
17. Post-operative treatment of malignant salivary gland tumours of the palate with iodine-125 brachytherapy.
Stannard CE; Hering E; Hough J; Knowles R; Munro R; Hille J
Radiother Oncol; 2004 Dec; 73(3):307-11. PubMed ID: 15588875
[TBL] [Abstract][Full Text] [Related]
18. 125I brachytherapy alone for recurrent or locally advanced adenoid cystic carcinoma of the oral and maxillofacial region.
Huang MW; Zheng L; Liu SM; Shi Y; Zhang J; Yu GY; Zhang JG
Strahlenther Onkol; 2013 Jun; 189(6):502-7. PubMed ID: 23625361
[TBL] [Abstract][Full Text] [Related]
19. Neutron Beam Radiation Therapy: An Overview of Treatment and Oral Complications When Treating Salivary Gland Malignancies.
Davis C; Sikes J; Namaranian P; Laramore G; Dillon JK
J Oral Maxillofac Surg; 2016 Apr; 74(4):830-5. PubMed ID: 26611376
[TBL] [Abstract][Full Text] [Related]
20. Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council.
Laramore GE; Krall JM; Griffin TW; Duncan W; Richter MP; Saroja KR; Maor MH; Davis LW
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):235-40. PubMed ID: 8407397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
